Melanotan I
Also known as: MT-1, Afamelanotide, Scenesse
The Photoprotective Tanning Peptide
FDA-approved (as Scenesse) for EPP patients, this melanocortin peptide stimulates natural melanin production for tanning and UV protection without sun exposure.
How It Works
Simple Explanation
Activates melanocortin receptors in skin cells to produce more melanin, your body's natural sunscreen pigment.
Technical Details
Synthetic alpha-MSH analog with high selectivity for MC1R. Stimulates melanogenesis in melanocytes, increasing eumelanin production for photoprotection.
Pharmacokinetics & Storage
Half-Life
~30 minutes
Duration in circulation
Storage Requirements
Protect from light. Reconstitute with bacteriostatic water.
Benefits
- Natural-looking tan without UV exposure
- Increased UV protection
- FDA-approved for EPP (erythropoietic protoporphyria)
- Longer-lasting tan than sun exposure
- May reduce skin cancer risk in high-risk individuals
Potential Side Effects
Nausea
Common initially
Usually subsides with continued use
Facial flushing
Common
Fatigue
Occasional
Mole darkening
Common
Monitor moles for changes
Research Highlights
Vitiligo Combination Therapy (2023)
Improved repigmentation when combined with narrowband UVB therapy in vitiligo patients
View StudyFrequently Asked Questions
What's the difference between Melanotan I and II?
Do I still need sun exposure?
Is Melanotan I legal?
Who Is It For
- EPP patients (FDA-approved use)
- Those seeking tan without UV damage
- Very fair-skinned individuals
- Those at high risk for UV damage
Who Should Avoid
- History of melanoma or skin cancer
- Many atypical moles
- Pregnant/nursing
- Liver disease
Research Dosing Protocols
Common Research Protocol
Implant: 16mg every 2 months (Scenesse). Research: 0.5-1mg injection
Administration Frequency (per studies)
Implant every 60 days, or injection protocols vary
Delivery Methods
👃 This peptide is also available in nasal spray form from select suppliers.
Available Forms
- • Subcutaneous implant (FDA-approved)
- • Subcutaneous injection (research)
- • Nasal spray (research)
💡 Some UV exposure enhances results but is not required
⚠️ Not Medical Advice: Dosing information is compiled from published research and clinical studies for educational purposes only. This is not a recommendation. All peptide research should be conducted by qualified professionals in controlled research environments. Consult a healthcare provider before considering any protocol.
⚠️ Important Disclaimer
This information is for educational purposes only and is not medical advice. Many peptides discussed are research compounds not approved for human use by the FDA. Always consult with a qualified healthcare provider before starting any peptide protocol. PepGains does not sell peptides and is not responsible for how this information is used. All timeline and efficacy information is based on published research and clinical trials - individual results may vary significantly.